David Walton

David Walton

Auto-generated profile, based on publicly available information

David Walton

The Kaiser Permanente Northern California Medical Group, Oakland, CA

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2015 in Annals of Internal Medicine
Verified
Journal Article
Closed access
EGErica P Gunderson
Erica P Gunderson
SHShanta R. Hurston
Shanta R. Hurston
XNXian Ning
Xian Ning
JLJoan C. Lo
Joan C. Lo
YCYvonne Crites
Yvonne Crites
CQCharles P. Quesenberry
Charles P. Quesenberry
Whether lactation prevents diabetes mellitus in women after a pregnancy with gestational diabetes is unclear. Investigators classified baseline glucose tolerance of postpartum women with recent ges... Background: Lactation improves glucose metabolism, but its role in preventing type 2 diabetes mellitus (DM) after gestational diabetes mellitus (GDM) remains uncertain. Objective: To evaluate lacta...

9 December 2011 in Diabetes Care
Verified
Journal Article
Open access
PDF file
EGErica P Gunderson
Erica P Gunderson
MHMonique M. Hedderson
Monique M. Hedderson
VCVicky Chiang
Vicky Chiang
YCYvonne Crites
Yvonne Crites
DWDavid Walton
David Walton
JSJoseph V. Selby
Joseph V. Selby
OBJECTIVE To examine the association between breastfeeding intensity in relation to maternal blood glucose and insulin and glucose intolerance based on the postpartum 2-h 75-g oral glucose tolerance test (OGTT) results at 6–9 weeks after a pregnancy with gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS We selected 522 participants enrolled into the Study of Women, Infant Feeding, and Type 2 Diabetes (SWIFT), a prospective observational cohort study of Kaiser Permanente Northern California members diagnosed with GDM using the 3-h 100-g OGTT by the Carpenter and Coustan criteria. Women were classified as normal, prediabetes, or diabetes according to American Diabetes Association criteria based on the postpartum 2-h 75-g OGTT results. RESULTS Compared with exclusive or mostly formula feeding (>17 oz formula per 24 h), exclusive breastfeeding and mostly breastfeeding (≤6 oz formula per 24 h) groups, respectively, had lower adjusted mean (95% CI) group differences in fasting plasma glucose (mg/dL) of −4.3 (−7.4 to −1.3) and −5.0 (−8.5 to −1.4), in fasting insulin (μU/mL) of −6.3 (−10.1 to −2.4) and −7.5 (−11.9 to −3.0), and in 2-h insulin of −21.4 (−41.0 to −1.7) and −36.5 (−59.3 to −13.7) (all P < 0.05). Exclusive or mostly breastfeeding groups had lower prevalence of diabetes or prediabetes (P = 0.02). CONCLUSIONS Higher intensity of lactation was associated with improved fasting glucose and lower insulin levels at 6–9 weeks’ postpartum. Lactation may have favorable effects on glucose metabolism and insulin sensitivity that may reduce diabetes risk after GDM pregnancy.

1 January 1998 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
DDDonald C. Dyson
Donald C. Dyson
KDKaren H. Danbe
Karen H. Danbe
JBJudith A. Bamber
Judith A. Bamber
YCYvonne M. Crites
Yvonne M. Crites
DFD. Robin Field
D. Robin Field
MAMary Anne Armstrong
Mary Anne Armstrong
Preterm birth is a major cause of perinatal morbidity and mortality. Whether the rate of preterm birth can be reduced by frequent contact between nurses and pregnant women or home monitoring of uterine activity is not known.

1 September 2011 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
EGErica P Gunderson
Erica P Gunderson
LCLisa A. Croen
Lisa A. Croen
VCVicky Chiang
Vicky Chiang
CYCathleen K. Ma Yoshida
Cathleen K. Ma Yoshida
DWDavid Walton
David Walton
AGAlan S. Go
Alan S. Go
OBJECTIVES: To estimate the incidence, describe the mortality, and identify independent predictors of peripartum cardiomyopathy, a very serious cardiovascular complication of pregnancy associated with maternal morbidity and mortality among otherwise healthy women without prior heart disease. METHODS: We identified all cases of diagnosed heart failure that occurred among women within 1 month before to 5 months after delivery of a liveborn neonate in Kaiser Permanente Northern California delivery hospitals between 1995 and 2004. Incident peripartum cardiomyopathy was confirmed from medical records documenting dilated cardiomyopathy with reduced left ventricular systolic function after excluding women with prior heart failure or valvular disease. Data sources included medical records, electronic clinical databases, and state birth and death files. RESULTS: Among 227,224 eligible women, we confirmed 110 recognized peripartum cardiomyopathy cases (incidence: 4.84 per 10,000 live births, 95% confidence interval 3.98–5.83). Independent predictors included maternal age of 25 years or older, non-Hispanic African American and Filipino groups, parity of 4 or greater, multiple gestation, severe anemia, pre-existing and pregnancy-related hypertensive disorders, and hemolysis, elevated liver enzymes, low platelets syndrome. Maternal death rate (per 1,000 person-years) was higher among cases (6.12) than noncases (0.23; P<.001). Neonates whose mothers developed peripartum cardiomyopathy experienced poorer clinical outcomes. CONCLUSION: Within a large, diverse northern California population, 1 of every 2,066 women delivering a liveborn neonate had recognized, confirmed peripartum cardiomyopathy, which was associated with higher maternal and neonatal death rates and worse neonatal outcomes. Several readily available patient characteristics can be used to identify women at risk for this severe pregnancy complication. LEVEL OF EVIDENCE: II

30 December 1999 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
DWDavid L. Walton
David L. Walton
CNCarol T. Norem
Carol T. Norem
ESEdgar J. Schoen
Edgar J. Schoen
GRG. Thomas Ray
G. Thomas Ray
CCChristopher J. Colby
Christopher J. Colby
Maternal serum chorionic gonadotropin is measured to screen for fetal chromosomal abnormalities. Whether the results can also be used to predict the risk of complications or an adverse outcome of pregnancy is not known.

1 October 2005 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
CNCarol T. Norem
Carol T. Norem
ESEdgar J. Schoen
Edgar J. Schoen
DWDavid L. Walton
David L. Walton
RKRobyn C. Krieger
Robyn C. Krieger
JOJennifer Oʼkeefe
Jennifer Oʼkeefe
GRG Thomas Ray
G Thomas Ray
This study was done to estimate the value of prenatal maternal serum alpha-fetoprotein (MSAFP) screening compared with that of routine ultrasonography in the diagnosis of neural tube defects (NTDs). An integrated database was used retrospectively to identify cases of NTDs among 219,000 consecutive pregnancy outcomes observed during a 7-year period at 40 Kaiser Permanente facilities in Northern California. We specifically examined types of NTD and the tests used to diagnose cases. We identified 189 NTD cases, 102 of which had received MSAFP screening. Results of MSAFP testing were negative in 25 (25%) of these 102 cases. Without other testing, these 25 NTD diagnoses would have been missed. These included 15 (38%) of the 40 spina bifida cases screened, 6 (67%) of the 9 encephalocele cases screened, and 4 (8%) of the 53 anencephaly cases screened. Of the 186 NTD cases diagnosed prenatally, 115 (62%) were initially detected by routine ultrasonography administered during the second trimester without knowledge of MSAFP values; 69 (37%) were diagnosed by targeted ultrasonography after MSAFP screening indicated a higher risk for NTD; and 2 (1%) were diagnosed by pathology examination after miscarriage. Compared with MSAFP performed alone for screening, routine second-trimester ultrasonography was more likely to discover an NTD.